BFC Planning, Inc.’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$175K Buy
567
+15
+3% +$4.65K 0.01% 985
2026
Q2
$155K Buy
552
+450
+441% +$118K 0.01% 1037
2026
Q1
$27.4K Sell
102
-4
-4% -$1.08K ﹤0.01% 1574
2025
Q4
$26.7K Sell
106
-15
-12% -$3.98K ﹤0.01% 1614
2025
Q3
$34.9K Sell
121
-1
-0.8% -$268 ﹤0.01% 1325
2025
Q2
$32.2K Hold
122
– – ﹤0.01% 1302
2025
Q1
$28.5K Buy
122
+7
+6% +$1.7K ﹤0.01% 1320
2024
Q4
$26.5K Hold
115
– – ﹤0.01% 1352
2024
Q3
$25.8K Buy
+115
New +$25.3K ﹤0.01% 1351

Other funds holding LH

BFC Planning, Inc.'s LH Position: Q3 2026 in Review

BFC Planning, Inc. increased its Labcorp (LH) stake by 2.7% in Q3 2026, buying an estimated $4.65K and bringing the position to 567 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #985.

BFC Planning, Inc. first reported a position in LH in Q3 2024 and has held it in 9 quarters since. 925 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • BFC Planning, Inc. held 567 shares of Labcorp worth $175K as of Q3 2026.
  • BFC Planning, Inc. bought 15 Labcorp shares in Q3 2026, an estimated $4.65K.
  • Labcorp made up 0.01% of BFC Planning, Inc.'s portfolio in Q3 2026, its #985 holding.
  • BFC Planning, Inc. first reported a position in Labcorp in Q3 2024 and has held it in 9 quarters since.
  • 925 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on BFC Planning, Inc.'s 13F filing for Q3 2026, filed 13 Nov 2026.